X

Trial Profile

Pilot study on glycaemic variability in type 2 diabetes mellitus patients with basal insulin and fixed combo oral antidiabetic treatment.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin glargine (Primary) ; Antihyperglycaemics; Insulin
Indications Type 2 diabetes mellitus
Focus Therapeutic Use
Sponsors Sanofi

Most Recent Events

05 Aug 2008 Primary endpoint identified as self monitoring blood glucose values as reported by ClinicalTrials.gov.
05 Aug 2008 The expected completion date for this trial is now 1 May 2006 as reported by Clinicaltrials.gov.
24 Nov 2006 Status change

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com